Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Medical devices / Imaging and radiotherapy equipment

SubmarketREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Imaging and radiotherapy equipment

Equipment that acquires anatomical or functional images or delivers radiation therapy, including X-ray, CT, MRI, ultrasound, mammography and radiotherapy systems, plus associated detectors and tables.

Market size
$131B
$131B ($122B–$134B) · 2026 · Bottom-up
Growth
+6.3%
$228B by 2035
Attractiveness
— /100
for B2B sellers
Evidence
Low confidence
2 sources · Bottom-up
Level
Submarket
Segmented by
Use case
Buyers
Hospitals, ambulatory imaging and radiation-oncology sites, physician practices
Buying centre
Radiology and oncology leadership, medical physics, clinical engineering, procurement, capital planning, finance
Maturity
Mature
Structure
Moderately concentrated
Buying triggers
  • New modality or system approvals
  • Hospital capital-equipment replacement cycles
  • New outpatient imaging-center capacity
  • Changes in diagnostic or radiotherapy reimbursement
Pains
  • Buyers face high upfront cost and uncertain utilization risk
  • Downtime has a large operational impact on clinical throughput
  • Facility, regulatory and clinical-workflow requirements complicate deployment
  • Interoperability with imaging and clinical systems remains a purchasing barrier
Scores (1–5)
Pain intensity—
Purchasing power—
Reachability—
Growth—
Growth drivers
  • Hospitals, imaging centers and radiotherapy facilities buy X-ray, CT, MRI, ultrasound, mammography and radiotherapy systems with detectors and tables.
  • Diagnostic and treatment demand supports utilization of clinical imaging and radiotherapy equipment.
  • Technological progress continues to create higher-performance system upgrades [5].
  • Replacement cycles and capacity expansion generate large, recurring vendor opportunities.
Headwinds
  • High capital cost and constrained hospital budgets lengthen purchase decisions.
  • Reimbursement constraints can limit utilization of new capacity [7].
  • Tighter regulatory requirements add approval and evidence costs [7].
  • Tariffs can raise the cost of imported components and finished systems [7].
Trends
  • Buyers increasingly evaluate workflow integration alongside image quality or treatment performance.
  • Installed-base modernization and detector replacement are important sources of recurring spend.
  • Imaging and radiotherapy remain capital-intensive, high-ticket purchases.
  • Service, uptime and interoperability requirements increasingly influence vendor selection.

Niches 5

Split by customer type.

Niche55/100

Imaging OEM service, detector and table component supply (B2B supplier tier)

Component and service suppliers selling detectors, patient tables, tubes, coils and OEM-compatible parts and service contracts into imaging and radiotherapy OEM installed bases and

—
Medical device OEMs (imaging and radiotherapy manufacturers) and hospital clinical engineering / biomedical equipment departments
not sizedOpen

Companies in this market 8

Named in public sources; linked to the source.

How this was sized

$131B ($122B–$134B) · 2026 · Bottom-up

No source provides a matching share for this submarket. Bottom-up share assumption: 21% of the scoped sector. Arithmetic: $623.37bn x 21% = $130.908bn in 2026. Low and high estimates apply 21% to the sector range from [4]. Constant-share forecast: $130.908bn x 1.0634^9 = $227.633bn in 2035.

Alongside it in Medical devices

// Sell into Imaging and radiotherapy equipment

AOS finds the biggest accounts in this submarket with a reason to talk now, maps their buying centre and prepares the outreach for your approval.